INS and primary biliary cholangitis: It has also been proposed that elevated lipocalin levels in PBC patients inhibit hepatic gluconeogenesis, resist hepatic fat accumulation, are anti-inflammatory, enhance insulin sensitivity, and reduce insulin resistance [38], thereby reducing hepatic steatosis [39].